Par Ingemar Jo­hans­son

Par Ingemar Jo­hans­son

Clinical Professor

Member of:

  • Clinical immunology


Publication year:
All
71 - 73 out of 73Page size: 10
  1. 2008
  2. Published

    Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials

    Jo­hans­son, Pär In­ge­mar , 2008, In: Vox Sanguinis. 95, 1, p. 1-7 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Scandinavian Guidelines "The massively bleeding patient"

    Gaarder, C., Naess, P. A., Frischknecht, C. E., Hakala, P., Handolin, L., Heier, H. E., Ivancev, K., Leppaniemi, A., Lippert, F., Lossius, H. M., Opdahl, H., Pillgram-Larsen, J., Roise, O., Skaga, N. O., Soreide, E., Stensballe, J., Tonnessen, E., Tottermann, A., Ortenwall, P., Ostlund, A. & 1 others, Jo­hans­son, Pär In­ge­mar , 2008, In: Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 97, 1, p. 15-36 21 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Transfusion packages for massively bleeding patients: the effect on clot formation and stability as evaluated by Thrombelastograph (TEG)

    Jo­hans­son, Pär In­ge­mar , Bochsen, L., Stensballe, J. & Secher, N. H., 2008, In: Transfusion and Apheresis Science. 39, 1, p. 3-8 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...4 5 6 7 8 Next

ID: 232690472